Clinical Trials Directory

Trials / Completed

CompletedNCT02254564

PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei

Status
Completed
Phase
Study type
Observational
Enrollment
17 (actual)
Sponsor
Seton Healthcare Family · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The main objective of this study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through PCR.

Detailed description

The main objective of this proposed study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through polymerase chain reaction or PCR. The goal of the project is to design an assay that can distinguish samples from skin scrapings containing scabies mites, eggs, or fecal material confirmed by clinic based microscopic evaluation (gold standard) from negative controls (i.e. scrapings for tinea and/or demodex folliculitis) that do not contain Sarcoptes scabiei. We hypothesize that specifically amplifying the unique regions of the Scabies genome using PCR can serve as a means to diagnosis infestations in humans. To address this question, we will optimize PCR amplification of known scabies samples then apply our procedure to DNA extracted from patient samples.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2017-08-01
Completion
2017-10-31
First posted
2014-10-02
Last updated
2018-07-03

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02254564. Inclusion in this directory is not an endorsement.